John Sarantopoulos
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Research top 5%
Papers in
- Oncology 62
- Cancer Treatment and Pharmacology 29
- Colorectal Cancer Treatments and Studies 11
- Pancreatic and Hepatic Oncology Research 11
- Co-authors
- Devalingam Mahalingam (38 shared papers)Alain C. Mita (28 shared papers)Monica Mita (25 shared papers)Anthony W. Tolcher (15 shared papers)Kamalesh K. Sankhala (15 shared papers)Tyler J. Curiel (3 shared papers)Francis J. Giles (4 shared papers)Jordi Rodón (5 shared papers)
- Journals
- Journal of Clinical Oncology (56 papers)Cancer Chemotherapy and Pharmacology (17 papers)Molecular Cancer Therapeutics (13 papers)Clinical Cancer Research (12 papers)Investigational New Drugs (5 papers)
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
John Sarantopoulos
141 papers receiving 3.2k citations
John Sarantopoulos's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 1.1k
- Cancer Research 316
- Molecular Biology 1.4k
- Immunology 419
- Genetics 201
Countries citing papers authored by John Sarantopoulos
This map shows the geographic impact of John Sarantopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sarantopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sarantopoulos more than expected).
Fields of papers citing papers by John Sarantopoulos
This network shows the impact of papers produced by John Sarantopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sarantopoulos. The network helps show where John Sarantopoulos may publish in the future.
Co-authors
The 25 scholars most cited alongside John Sarantopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 271 |
| 2 | 2014 | 245 | |
| 3 | 2009 | 238 | |
| 4 | 2014 | 187 | |
| 5 | 2013 | 146 | |
| 6 | 2011 | 140 | |
| 7 | 2015 | 140 | |
| 8 | 2010 | 86 | |
| 9 | 2010 | 86 | |
| 10 | 2017 | 74 | |
| 11 | 2019 | 72 | |
| 12 | 2012 | 70 | |
| 13 | 2016 | 69 | |
| 14 | 2018 | 61 | |
| 15 | 2012 | 60 | |
| 16 | 2020 | 57 | |
| 17 | 2011 | 49 | |
| 18 | 2017 | 48 | |
| 19 | 2019 | 47 | |
| 20 | 2008 | 40 |
About John Sarantopoulos
John Sarantopoulos is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 144 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (29 papers), Lung Cancer Treatments and Mutations (17 papers), Cancer, Hypoxia, and Metabolism (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers), Colorectal Cancer Treatments and Studies (11 papers), Pancreatic and Hepatic Oncology Research (11 papers), Microtubule and mitosis dynamics (9 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (316 citations), Molecular Biology (1.4k citations), Immunology (419 citations) and Genetics (201 citations). John Sarantopoulos has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Devalingam Mahalingam, Alain C. Mita, Monica Mita, Anthony W. Tolcher, Kamalesh K. Sankhala, Tyler J. Curiel, Francis J. Giles, Jordi Rodón, Chia‐Chi Lin and Jennifer S. Carew. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Molecular Cancer Therapeutics, Clinical Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.